Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

BGI Shenzhen Plans IPO

publication date: Sep 3, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BGI Shenzhen, the world’s largest sequencing company, is planning to split itself in two and IPO its institutional sequencing business. The other half, its “retail” diagnostic sequencing segment, which serves the hospital/clinic market, will remain private. BGI hasn’t officially announced its IPO, so no financial details for the transaction are available, nor has the company named its target exchange. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners